Drug Trial Radar · NCT05570253
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
Last checked: Nov 20, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
55
Planned (sponsor's estimate)
Start
Oct 3, 2022
Primary completion
Oct 2027
Study completion Oct 2027
Sponsor
- Lead sponsor
- Memorial Sloan Kettering Cancer CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- SynDevRx, Inc.
- First posted
- Oct 6, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The researchers are doing this study to find out whether the study drug, SDX-7320, when combined with the standard chemotherapy eribulin, is an effective treatment for people with TNBC and metabolic dysfunction. The researchers will also look at whether the study treatment (SDX-7320 combined with eribulin) is safe and causes few or mild side effects in participants. The researchers will compare this treatment approach to eribulin alone.
Conditions
- Breast Cancer
- Metastatic Triple-Negative Breast Cancer
Interventions
EribulinDrug
Eribulin 1.4 mg/m2 IV on days 1 and 8 of an every 21 day cycle.
SDX-7320Drug
SDX-7320 at the dose of 49 mg/m2 SC on a Q14D basis
PlaceboOther
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- change in insulin resistance scores (HOMA-IR)Time frame: 1 year
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
BAPTIST ALLIANCE - MCI (Data Collection Only)
Miami, Florida · Recruiting
Emory University (Data Collection Only)
Atlanta, Georgia · Recruiting
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Basking Ridge, New Jersey · Recruiting
Hackensack Meridian Health
Hackensack, New Jersey · Recruiting
Memorial Sloan Kettering Monmouth (All Protocol Activities)
Middletown, New Jersey · Recruiting
Memorial Sloan Kettering Bergen (All Protocol Activities)
Montvale, New Jersey · Recruiting
Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)
Commack, New York · Recruiting
Memorial Sloan Kettering Westchester (All Protocol Activities)
Harrison, New York · Recruiting
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York · Recruiting
Memorial Sloan Kettering Nassau (All Protocol Activities)
Uniondale, New York · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.